| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 01/12/2005 | EP0318554B2 Targeted multifunctional proteins |
| 01/12/2005 | CN1564827A Polypeptide purification method |
| 01/12/2005 | CN1564826A Human G-protein chemokine receptor (CCR5) HDGNR10 |
| 01/12/2005 | CN1563092A Recombining single chained three specific antibodies of anti CCA, anti CD 3, anti CD 28 through genetic engineering |
| 01/12/2005 | CN1184235C Chimeric polypeptides, method for production and uses thereof |
| 01/12/2005 | CN1184233C Erytrocyte-stimulating factor coupling |
| 01/11/2005 | US6841382 Nucleotide sequences coding protein for use in treatment of cancer, inflammation, arthritis and psoriasis |
| 01/11/2005 | US6841367 Human receptor tyrosine kinase, KDR |
| 01/11/2005 | US6841363 Preparation of capped mRNA |
| 01/11/2005 | US6841361 Methods of producing recombinant insulin from novel fused proteins |
| 01/11/2005 | CA2337099C Enzymes for biopolymer production |
| 01/06/2005 | WO2004085478A3 Improved fc fusion proteins |
| 01/06/2005 | US20050004351 Therapeutic and diagnostic domain 1 beta2GP1 polypeptides and methods of using same |
| 01/06/2005 | US20050004034 Human C-Maf compositions and methods of use therefor |
| 01/06/2005 | US20050004027 Administering a compound which blocks endothelial growth factor |
| 01/06/2005 | US20050003504 Alkaline protease from Bacillus gibsonii (DSM 14391) and washing and cleaning products comprising said alkaline protease |
| 01/06/2005 | US20050003473 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase |
| 01/06/2005 | US20050003451 Immunoglobulin for use in diagnosis, prevention and treatment of infection, autoimmune, inflammatory and cell proliferative diseases; immunotherapy |
| 01/06/2005 | US20050003424 Nucleotide sequences coding ligand-binding receptor polypeptide for use in treating and preventing male sterility; for identifying modulators which can be used as male contraceptives |
| 01/06/2005 | US20050003353 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 01/06/2005 | US20050003352 Comprises recombinant mitochondrial transport protein for diagnosis, prevention and treatment of alzheimer's, diabetes, parkinson's, huntington's, cancers |
| 01/06/2005 | US20050002944 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 01/06/2005 | US20050002902 Increasing active half life; reducing dosage and side effects |
| 01/05/2005 | EP1493815A1 Novel fusion protein recovery and purification methods |
| 01/05/2005 | EP1493028A2 Phage displayed pdz domain ligands |
| 01/05/2005 | EP1492819A2 Anti-idiotype anti-cea antibody molecules and its use as cancer vaccine |
| 01/05/2005 | EP1492811A1 Muteins of the c5a anaphylatoxin, nucleic acid molecules encoding such muteins, and pharmaceutical uses of muteins of the c5a anaphylatoxin |
| 01/05/2005 | EP1492563A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 01/05/2005 | EP1492559A2 Truncated 24 kda basic fibroblast growth factor |
| 01/05/2005 | EP1397386A4 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same |
| 01/05/2005 | DE19957065B4 Screening-Verfahren für Arzneistoffe A screening method for drugs |
| 01/05/2005 | CN1561394A Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| 01/05/2005 | CN1561232A Therapeutic agent comprising a B-subunit of a protein toxin |
| 01/05/2005 | CN1561229A Virus coat protein/receptor chimeras and methods of use |
| 01/05/2005 | CN1561223A New drug |
| 01/05/2005 | CN1560082A Chimeric antibod of antihumon recombined basicity fibroblast growth factor and construction and using thereof |
| 01/05/2005 | CN1560080A Corpuscles of stannius protein, stanniocalcin |
| 01/05/2005 | CN1183155C Peptide useful as ligand |
| 01/04/2005 | US6838261 Nucleic acids encoding anti-CD40 proteins and methods of producing recombinant anti-CD40 proteins |
| 01/04/2005 | US6838260 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 12/30/2004 | US20040267003 Nucleotide and amino aicd sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 12/30/2004 | US20040266994 Type-1 ribosome-inactivating protein |
| 12/30/2004 | US20040266684 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 12/30/2004 | US20040265975 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence |
| 12/30/2004 | US20040265913 Tumor necrosis factors (TNF); humanized/chimeric monoclonal antibodies; fab fragments; hybridomas, host cells, Chinese Hamster Ovary cells |
| 12/30/2004 | US20040265818 Histidine phosphatase interacting protein with 180kd |
| 12/30/2004 | US20040265809 Polypeptides derived from retinoic acid-related orphan receptor(ror) and their applications |
| 12/30/2004 | US20040265801 Immunoassays for anti-HCV antibodies |
| 12/30/2004 | US20040265321 A dimeric fusion protein having two identical polypeptide chains, each chain wtih an extracellular region of an activating Fc gamma R containing an Fc binding site, joined to a molecule that binds an Fc gamma Rn; dimeric fusion protein specifically binds an immune complex |
| 12/30/2004 | US20040265316 An antibody which specifically binds to a Fhit (fragile histidine triad) protein or derivative |
| 12/30/2004 | US20040265307 Anti-IGF-I receptor antibody |
| 12/30/2004 | US20040265300 Targeting cancer cell; induction or prevention of apoptosis in eukaryotic cells; a fusion peptide contains a viral apoptotic peptide and an antibody fragment; recombinant host cell comprising the vector, encoding chimeric polypeptide; bioassay monitoring apoptosis activity; drug target |
| 12/29/2004 | WO2004113539A2 Method for producing a recombinant protein of interest and protein thus produced |
| 12/29/2004 | WO2004113376A1 Modified oleosins |
| 12/29/2004 | WO2004099418A8 Fused protein |
| 12/29/2004 | WO2004084942A3 Methods and means to suppress symptoms of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (gitr or tnfrsf18) |
| 12/29/2004 | WO2002089747A3 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 12/29/2004 | EP1491556A1 Humanized immunoglobulins and their production and use |
| 12/29/2004 | EP1490406A1 Costimulatory molecule and its use |
| 12/29/2004 | EP1490395A1 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity |
| 12/29/2004 | EP1490386A2 Novel polypeptides and nucleic acids encoding the same |
| 12/29/2004 | EP1490109A2 Egfr ligands and methods of use |
| 12/29/2004 | EP1284998B1 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
| 12/29/2004 | EP1161456B1 Ccr5 binding antibody constructs and their use for treating autoimmune diseases |
| 12/29/2004 | EP0935651B1 THERAPY FOR alpha-GALACTOSIDASE A DEFICIENCY |
| 12/29/2004 | EP0785946B1 Materials for the production of nanometer structures and use thereof |
| 12/29/2004 | CN1558916A Compositions and methods for generating chimeric heteromultimers |
| 12/29/2004 | CN1558775A Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases |
| 12/29/2004 | CN1558774A Angiotensin peptide-carrier conjugates and uses thereof |
| 12/29/2004 | CN1557960A Method for separating antibiotic peptide and separated antibiotic peptide |
| 12/29/2004 | CN1557954A Expression and application of transduction peptides - human insulinogen fusion protein |
| 12/29/2004 | CN1181890C Use of enterobacterium protein OmpA in the preparation of antigen presentation cells specified targeting medicine |
| 12/29/2004 | CA2528845A1 Modified oleosins |
| 12/28/2004 | US6835809 Thrombopoietic compounds |
| 12/23/2004 | WO2004111090A2 Molecules for targeting and releasing therapeutic compounds, and the use thereof |
| 12/23/2004 | WO2004111075A2 Alternative reading frame polypeptides for treatment |
| 12/23/2004 | WO2003076569A3 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same |
| 12/23/2004 | US20040260069 Modified anti-tnf aplha antibody |
| 12/23/2004 | US20040259165 Non-oligomerizing tandem fluorescent proteins |
| 12/23/2004 | US20040259092 Nogo receptor homologues and their use |
| 12/23/2004 | US20040258709 Hepatitis B virus polypeptides |
| 12/23/2004 | US20040258704 Bovine lactation associated immunotropic protein (CD14), encoding gene and application in B cell activation |
| 12/23/2004 | US20040258678 Isolated nucleic acid having high identity to sequence 215; vectors, host cells, antibodies |
| 12/23/2004 | DE10235248B4 Fusionsprotein mit verstärkter in vivo-Aktivität von Erythropoietin Fusion protein with enhanced in vivo activity of erythropoietin |
| 12/23/2004 | CA2563361A1 Cell permeable conjugates of peptides for inhibition of protein kinases |
| 12/23/2004 | CA2528948A1 Mutants of core 2 b-1,6-n-acetylglycosaminyltransferase |
| 12/23/2004 | CA2528186A1 Molecules for targeting and releasing therapeutic compounds, and the use thereof |
| 12/23/2004 | CA2514288A1 Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease |
| 12/22/2004 | EP1489100A2 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 12/22/2004 | EP1489099A2 Antibodies that bind the CD40CR receptor |
| 12/22/2004 | EP1487877A2 Compositions and methods for the diagnosis and treatment of tumor |
| 12/22/2004 | EP1487870A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 12/22/2004 | EP1487868A1 Chimeric delta endotoxin protein of cry1ea and cry1ca |
| 12/22/2004 | EP1487857A1 Lymphatic and blood endothelial cell genes |
| 12/22/2004 | EP1487854A2 Novel isoforms of vascular endothelial ell growth inhibitor |
| 12/22/2004 | EP1487487A2 Methods and compositions for prevention, diagnosis, and treatment of cancer using bispecific molecules |
| 12/22/2004 | EP1487480A2 Fusion molecules and methods for treatment of immune diseases |
| 12/22/2004 | CN1556114A Human dry cell factor macrophage clong irritant factor bifunction protein and its preparation |
| 12/22/2004 | CN1181099C Anticoagulation and thrombolytic thrombus target fusion mA5UKB |
| 12/21/2004 | US6833441 Compositions and methods for generating chimeric heteromultimers |